Advertisement
Home Tags Health Costs

Tag: Health Costs

Participation in the Medicare Shared Savings Program is associated with an overall reduction in post-acute spending

Medicare Shared Savings Linked to Lower Post-Acute Spending

And, performance is similar on standardized costs for Oregon, Colorado Medicaid ACO models
Cardiovascular disease is increasing in the United States

AHA: CVD Expected to Cost U.S. $1.1 Trillion Per Year by 2035

American Heart Association estimates CVD-related disease in nearly half of Americans in <20 years
Lower intensity of peak daily energy expenditure estimated from ambulatory electrocardiographic monitoring is associated with increased health care utilization

Daily Energy Expenditure Linked to Health Care Utilization

Findings for energy expenditures estimated from ambulatory ECG monitoring
Nearly 6 percent of the world's health care spending is tied to smoking

Smoking Imposes Heavy Burden on Global Economy

Tobacco-related diseases caused 12 percent of deaths among smokers aged 30 to 69 in 2012
For patients with type 2 diabetes mellitus

Economic Benefit for Combo Statin/TG-Specific Tx in T2DM

Greatest cost reduction for statin/TG-specific-treated patients with TG level drop of ≥30 percent
For patients with newly diagnosed atrial fibrillation

Lower Inpatient Costs for Dabigatran, Rivaroxaban in A-Fib

Lower inpatient costs with dabigatran, rivaroxaban versus warfarin for newly diagnosed atrial fibrillation
Many doctors bill their private-paying patients two

Physician Excess Charges Create Financial Burden for Patients

Fees affect uninsured Americans, privately insured patients who use out-of-network physicians
The effect of price information varies for pediatric- and adult-focused clinicians

Effect of Providing Price Info Varies for Type of Clinician

No difference in rate at which orders were placed across study arms for pediatric-focused clinicians
Left ventricular assist devices improve quality of life in ambulatory patients with advanced heart failure

Left Ventricular Assist Device Ups QoL in Ambulatory Heart Failure

Left ventricular assist devices increase quality-adjusted life-years, readmissions, and costs
The excessive regulatory regime at the U.S. Food and Drug Administration is an important driver of high drug prices

Excessive FDA Regulation Driving High Drug Prices

First-in-class drugs are fast-tracked while follow-on drugs can take up to 15 years to be approved